ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

This study is ongoing, but not recruiting participants.
Study NCT00075868.   Last updated on October 18, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Anal Cancer
Cancer-Related Problem/Condition
Colorectal Cancer
2 Additional conditions recognized in this trial
Anus Neoplasms
Colorectal Neoplasms
Rectal Neoplasms
3 More general conditions related to this trial
Anus Diseases
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Intestinal Diseases
Intestinal Neoplasms
Neoplasms
Neoplasms by Site
Rectal Diseases
4 Interventions listed in this trial
octreotide acetate
5 Additional drug interventions recognized in this trial
Octreotide
6 More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
7 Sponsors listed in this trial
Radiation Therapy Oncology Group
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers